A unique collection of 75 calcium channel blockers and agonists for high throughput and high content screening;Targeting different subtypes of calcium channels, such as L-type, T-type, N-type, and receptor-operated calcium channels.Bioactivity and safety confirmed by pre-clinical research and clinical trials, some of which are FDA approved;Detailed compound information with structure, target, activity, IC50 value, and biological activity description;Structurally diverse, medicinally active, and cell permeable;NMR and HPLC validated to ensure high purity and quality;